Drawing for HIDEFRA

USPTO serial 79233561

HIDEFRA

Reviewed by CopyMark Law Group

Reg. 5619786Status 709
Filing date
Status date
Registration date
Dec 4, 2018
Examiner
AIKENS, RONALD E
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HIDEFRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus for diagnosing or treating respiratory conditions, diabetes, cardiovascular and metabolic disorders, diseases of the nervous system, inflammatory disorders, infectious diseases and for use in dermatologySECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 3, 2026INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Nov 3, 2026INPCINVALIDATION PROCESSED—
Feb 20, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 20, 2025C71TCANCELLED SECTION 71—
Jan 19, 2024CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 1, 2019GPNXNOTIFICATION PROCESSED BY IB—
Jan 16, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 16, 2019FIMPFINAL DISPOSITION PROCESSED—
Jan 3, 2019GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Dec 4, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 21, 2018GPNXNOTIFICATION PROCESSED BY IB—
Sep 18, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 5, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 5, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 29, 2018NPUBNOTICE OF PUBLICATION—
Jul 5, 2018PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jul 4, 2018NPUBNOTICE OF PUBLICATION—
Jun 19, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 19, 2018DOCKASSIGNED TO EXAMINER—
Jun 16, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 12, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 11, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 7, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance